agilon health (NYSE:AGL) Price Target Raised to $3.00 at Stifel Nicolaus

agilon health (NYSE:AGLFree Report) had its price objective raised by Stifel Nicolaus from $2.00 to $3.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a hold rating on the stock.

A number of other equities research analysts have also recently commented on AGL. TD Cowen decreased their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Royal Bank of Canada reissued an “outperform” rating and set a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. Sanford C. Bernstein upped their price target on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research note on Wednesday, January 15th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Finally, Barclays lowered their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, agilon health has a consensus rating of “Hold” and an average price target of $3.95.

Read Our Latest Analysis on AGL

agilon health Stock Down 9.4 %

Shares of AGL stock opened at $3.29 on Wednesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a one year low of $1.50 and a one year high of $7.73. The company’s fifty day moving average price is $2.91 and its 200-day moving average price is $3.04. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of -3.50 and a beta of 0.66.

Insider Activity

In related news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. The trade was a 27.93 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 77,500 shares of company stock worth $169,600. 3.20% of the stock is currently owned by corporate insiders.

Institutional Trading of agilon health

A number of institutional investors have recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of agilon health by 24.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock valued at $1,516,000 after acquiring an additional 157,610 shares during the period. Two Sigma Advisers LP grew its holdings in agilon health by 4,393.5% during the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock valued at $914,000 after purchasing an additional 470,100 shares during the last quarter. Two Sigma Investments LP raised its position in agilon health by 73.7% in the 4th quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock worth $1,630,000 after purchasing an additional 363,855 shares during the period. State of Wyoming lifted its stake in agilon health by 89.3% in the fourth quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after purchasing an additional 57,802 shares during the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in shares of agilon health during the fourth quarter valued at approximately $768,000.

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.